Akari Therapeutics Plc (AKTX)
0.3925
-0.02
(-4.27%)
USD |
NASDAQ |
Dec 12, 14:47
Akari Therapeutics Free Cash Flow: -9.678M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -98.65M |
| Cellectis SA | -34.73M |
| Biodexa Pharmaceuticals Plc | -14.30M |
| NuCana Plc | -18.19M |
| Autolus Therapeutics Plc | -306.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.102M |
| Cash from Financing (Quarterly) | 1.876M |
| Free Cash Flow Per Share (Quarterly) | -0.0643 |
| Free Cash Flow to Equity (Quarterly) | -2.672M |
| Free Cash Flow to Firm (Quarterly) | -1.999M |
| Free Cash Flow Yield | -80.91% |